Search

everythinglearnresearchcommunity

for

Search:↓

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Finasteride and dutasteride might lower melanoma risk.

Male pattern baldness may be linked to prostate cancer risk.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Long-term diabetes is linked to lower prostate cancer risk.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Finasteride's effects on prostate cancer are not clear from this text.

Male pattern baldness may predict prostate cancer risk.

Haematospermia is usually harmless but needs careful checking to ease anxiety and find any serious causes.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Finasteride improves prostate cancer detection in PSA test.

Bald men may have a lower risk of testicular cancer.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Finasteride shows promise for preventing prostate cancer, but more research is needed.

A 22-year-old homosexual man was diagnosed with secondary syphilis, genital warts, and HIV, highlighting the high STI risk in men who have sex with men.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Finasteride, often used for hair loss, can potentially cause cataracts.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

A rare skin cancer on a man's elbow was successfully treated with surgery, showing no recurrence after one year.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Certain natural compounds called terpenes may help prevent prostate cancer.

Micro-CT helps identify suitable areas for surgical procedures based on blood vessel distribution in hypospadias-affected rats.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.